1. Home
  2. VRA vs ENTX Comparison

VRA vs ENTX Comparison

Compare VRA & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

SELL

Current Price

$5.81

Market Cap

156.6M

ML Signal

SELL

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$2.63

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
ENTX
Founded
1982
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
156.6M
147.4M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
VRA
ENTX
Price
$5.81
$2.63
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $9.75
AVG Volume (30 Days)
500.6K
★ 574.1K
Earning Date
09-15-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 20.47
N/A
EPS
N/A
★ 0.22
Revenue
★ $416,097,000.00
$42,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.56
N/A
P/E Ratio
★ N/A
$11.45
Revenue Growth
★ N/A
N/A
52 Week Low
$1.39
$0.91
52 Week High
$5.93
$4.20

Technical Indicators

Market Signals
Indicator
VRA
ENTX
Relative Strength Index (RSI) 77.17 46.12
Support Level $2.99 $1.46
Resistance Level N/A $2.78
Average True Range (ATR) 0.33 0.17
MACD 0.08 -0.01
Stochastic Oscillator 95.38 36.28

Price Performance

Historical Comparison
VRA
ENTX

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: